Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,931 public trials 462 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients

NCT00001669

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
View Trial Details
Completed

Rolipram to Treat Multiple Sclerosis

NCT00011375

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
View Trial Details
Completed

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis

NCT00381264

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • South Florida Medical Research Aventura, Florida, United States
  • Sunrise Clinical Research, Inc. Hollywood, Florida, United States
  • Naples Anesthesia and Pain Associates Naples, Florida, United States
  • Lazlo Mate, MD West Palm Beach, Florida, United States
View Trial Details

Related conditions